Last 12 months
Inside the activity.
0 purchase rows · 202 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 36 |
| Dec 2025 | 0 | 34 |
| Jan 2026 | 0 | 66 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 17 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 10 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 24 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 08, 2024 Filed Apr 11, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 3,730 | $244.12 | $910,566.48 |
DisclosureSEC source: 0000950170-24-043502 · ownership.xml · nonDerivative · entry 3 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 206,834 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.43 to $244.42, inclusive. Read SEC document |
| April 08, 2024 Filed Apr 11, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 1,441 | $242.95 | $350,094.26 |
DisclosureSEC source: 0000950170-24-043502 · ownership.xml · nonDerivative · entry 2 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 210,564 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.39 to $243.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below. Read SEC document |
| April 08, 2024 Filed Apr 11, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
Exercise / conversionCommon Stock | 26,270 | $9.45 | $248,251.50 |
DisclosureSEC source: 0000950170-24-043502 · ownership.xml · nonDerivative · entry 1 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 212,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 27,506 | $0.00 Strike: $9.45 | $0.00 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · derivative · entry 26 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,240 Underlying: Common Stock · 27,506 shares Expires 2026-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F20 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 5,278 | $245.53 | $1,295,924.23 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 22 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 458,999 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.03 to $245.88, inclusive. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 2,079 | $244.45 | $508,213.42 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 21 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 464,277 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.03 to $245.02, inclusive. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 8,989 | $243.33 | $2,187,287.98 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 20 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 466,356 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.00 to $243.95, inclusive. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 8,817 | $242.61 | $2,139,068.56 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 19 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 475,345 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.00 to $242.99, inclusive. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 700 | $241.14 | $168,798.91 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 18 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 484,162 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.67 to $241.64, inclusive. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 1,643 | $240.11 | $394,496.79 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 17 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 484,862 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.57 to $240.52, inclusive. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
Exercise / conversionCommon Stock | 27,506 | $9.45 | $259,931.70 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 16 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 486,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 27,613 | $0.00 Strike: $9.45 | $0.00 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · derivative · entry 27 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 232,526 Underlying: Common Stock · 27,613 shares Expires 2026-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F22 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 444 | $245.92 | $109,189.41 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 23 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 185,735 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F20 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.86 to $246.02, inclusive. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 5,228 | $245.35 | $1,282,668.89 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 22 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186,179 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F19 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.83 to $245.81, inclusive. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 3,966 | $244.22 | $968,587.62 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 21 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 191,407 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.80 to $244.79, inclusive. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 9,264 | $243.20 | $2,253,015.92 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 20 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 195,373 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.80 to $243.79, inclusive. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 6,679 | $242.42 | $1,619,097.80 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 19 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 204,637 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.795 to $242.78, inclusive. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 612 | $241.15 | $147,582.45 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 18 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,316 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.67 to $241.64, inclusive. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 1,420 | $240.10 | $340,939.02 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 17 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,928 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.67 to $240.64, inclusive. Read SEC document |
| April 05, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
Exercise / conversionCommon Stock | 27,613 | $9.45 | $260,942.85 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 16 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,537 | $0.00 Strike: $9.45 | $0.00 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · derivative · entry 25 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,746 Underlying: Common Stock · 18,537 shares Expires 2026-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F20 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 100 | $248.23 | $24,823.00 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 15 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 458,999 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 711 | $247.23 | $175,778.25 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 14 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 459,099 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.78 to $247.68, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 1,653 | $246.01 | $406,658.33 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 13 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 459,810 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.52 to $246.50, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 2,734 | $245.06 | $670,005.80 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 12 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 461,463 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.49 to $245.47, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 435 | $244.01 | $106,142.87 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 11 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 464,197 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.40 to $244.39, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 3,085 | $242.71 | $748,764.67 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 10 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 464,632 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.38 to $243.35, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 5,619 | $241.85 | $1,358,970.88 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 9 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 467,717 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.37 to $242.36, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 4,200 | $240.88 | $1,011,678.78 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 8 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 473,336 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.33 to $241.29, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
Exercise / conversionCommon Stock | 18,537 | $9.45 | $175,174.65 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 7 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 477,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,710 | $0.00 Strike: $9.45 | $0.00 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · derivative · entry 26 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 260,139 Underlying: Common Stock · 18,710 shares Expires 2026-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F22 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 200 | $248.43 | $49,685.00 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 15 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 185,735 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.41 to $248.44, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 737 | $247.14 | $182,141.07 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 14 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 185,935 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.80 to $247.54, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 1,558 | $246.13 | $383,470.85 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 13 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186,672 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.70 to $246.65, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 2,549 | $245.14 | $624,857.02 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 12 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 188,230 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.65 to $245.61, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 627 | $244.31 | $153,184.75 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 11 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 190,779 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.65 to $244.63, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 1,467 | $243.00 | $356,481.73 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 10 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 191,406 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.60 to $243.55, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 5,299 | $242.25 | $1,283,678.51 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 9 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 192,873 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.59 to $242.57, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 6,273 | $241.07 | $1,512,222.07 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 8 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 198,172 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.52 to $241.46, inclusive. Read SEC document |
| April 04, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
Exercise / conversionCommon Stock | 18,710 | $9.45 | $176,809.50 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 7 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 204,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 27,845 | $0.00 Strike: $9.45 | $0.00 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · derivative · entry 24 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,283 Underlying: Common Stock · 27,845 shares Expires 2026-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F20 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| April 03, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 2,089 | $246.32 | $514,572.72 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 6 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 458,999 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.12 to $246.70, inclusive. Read SEC document |
| April 03, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 18,917 | $245.34 | $4,641,013.55 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 5 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 461,088 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.11 to $246.10, inclusive. Read SEC document |
| April 03, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 4,070 | $244.68 | $995,853.71 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 4 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 480,005 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.11 to $245.10, inclusive. Read SEC document |
| April 03, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 2,634 | $243.68 | $641,866.03 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 3 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 484,075 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.11 to $244.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below. Read SEC document |
| April 03, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
SaleCommon Stock | 135 | $242.00 | $32,670.00 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 2 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 486,709 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. Read SEC document |
| April 03, 2024 Filed Apr 6, 2024 00:50 UTC |
Taub RebeccaDirector · Pres., R&D, and CMO
|
Exercise / conversionCommon Stock | 27,845 | $9.45 | $263,135.25 |
DisclosureSEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 1 Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 486,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 27,407 | $0.00 Strike: $9.45 | $0.00 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · derivative · entry 25 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 278,849 Underlying: Common Stock · 27,407 shares Expires 2026-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F22 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable. Read SEC document |
| April 03, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 1,821 | $246.31 | $448,529.96 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 6 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 185,735 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.09 to $246.57, inclusive. Read SEC document |
| April 03, 2024 Filed Apr 6, 2024 00:50 UTC |
FRIEDMAN PAUL ADirector
|
SaleCommon Stock | 18,806 | $245.34 | $4,613,822.67 |
DisclosureSEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 5 FRIEDMAN PAUL A · CIK 0001236927 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,556 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.04 to $246.01, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.